Schaefer, A.; Sachpekidis, C.; Diella, F.; Doerks, A.; Kratz, A.-S.; Meisel, C.; Jackson, D.B.; Soldatos, T.G.
Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients. Cancers 2020, 12, 1008.
https://doi.org/10.3390/cancers12041008
AMA Style
Schaefer A, Sachpekidis C, Diella F, Doerks A, Kratz A-S, Meisel C, Jackson DB, Soldatos TG.
Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients. Cancers. 2020; 12(4):1008.
https://doi.org/10.3390/cancers12041008
Chicago/Turabian Style
Schaefer, Anne, Christos Sachpekidis, Francesca Diella, Anja Doerks, Anne-Sophie Kratz, Christian Meisel, David B. Jackson, and Theodoros G. Soldatos.
2020. "Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients" Cancers 12, no. 4: 1008.
https://doi.org/10.3390/cancers12041008
APA Style
Schaefer, A., Sachpekidis, C., Diella, F., Doerks, A., Kratz, A.-S., Meisel, C., Jackson, D. B., & Soldatos, T. G.
(2020). Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients. Cancers, 12(4), 1008.
https://doi.org/10.3390/cancers12041008